in this issue
People & Business :: M&A
Moberg Pharma acquires three OTC brands in the US from Bayer HealthCare
5:57 AM MST | December 6, 2013 | Natasha Alperowicz
Moberg Pharma (Stockholm) announced today that it has signed a deal to acquire three well-established OTC brands in the United States from Bayer HealthCare for 32 million Swedish kronor ($4.8 million) in cash. Total annual sales for the brands are approximately SK20 million. The transaction is expected to close before the end of 2013. The acquired portfolio includes Domeboro, a topical astringent used for relieving itch and minor skin irritations; Vanquish, an internal analgesic; and Fergon, an iron supplement. The brands will be sold through...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee